Westside Investment Management’s Anixa Biosciences ANIX Stock Holding History

Westside Investment Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Sell	43,000 -4,000	-9%	-$11.1K	0.02%	391
2026 Q1	$121K	Buy	47,000 +3,000	+7%	+$8.88K	0.02%	370
2025 Q4	$137K	Buy	44,000 +9,000	+26%	+$36.9K	0.02%	334
2025 Q3	$116K	Hold	35,000	–	–	0.02%	373
2025 Q2	$116K	Hold	35,000	–	–	0.02%	324
2025 Q1	$100K	Hold	35,000	–	–	0.02%	313
2024 Q4	$81.2K	Hold	35,000	–	–	0.02%	337
2024 Q3	$110K	Buy	35,000 +21,100	+152%	+$64.9K	0.02%	307
2024 Q2	$30.7K	Hold	13,900	–	–	0.01%	463
2024 Q1	$43.4K	Hold	13,900	–	–	0.01%	398
2023 Q4	$53.9K	Buy	13,900 +1,000	+8%	+$3.37K	0.01%	349
2023 Q3	$42.2K	Sell	12,900 -900	-7%	-$3.15K	0.01%	369
2023 Q2	$44.2K	Buy	+13,800	New	+$53.2K	0.01%	371

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Westside Investment Management's ANIX Position: Q2 2026 in Review

Westside Investment Management reduced its Anixa Biosciences (ANIX) stake by 8.5% in Q2 2026, selling an estimated $11.1K and leaving 43,000 shares worth $120K. The position accounts for 0.02% of the portfolio, ranked #391.

Westside Investment Management first reported a position in ANIX in Q2 2023 and has held it in 13 quarters since. The position peaked at $137K in Q4 2025. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Westside Investment Management held 43,000 shares of Anixa Biosciences worth $120K as of Q2 2026.
Westside Investment Management sold 4,000 Anixa Biosciences shares in Q2 2026, an estimated $11.1K.
Anixa Biosciences made up 0.02% of Westside Investment Management's portfolio in Q2 2026, its #391 holding.
Westside Investment Management first reported a position in Anixa Biosciences in Q2 2023 and has held it in 13 quarters since.
Westside Investment Management's Anixa Biosciences position peaked at $137K in Q4 2025.
62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.